Lucknow, India

Shailendra Kumar Dhar Dwivedi

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shailendra Kumar Dhar Dwivedi: Innovator in Cancer Treatment

Introduction

Shailendra Kumar Dhar Dwivedi is a notable inventor based in Lucknow, India. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of various types of cancer. His innovative work has the potential to impact the lives of many patients suffering from chronic diseases.

Latest Patents

Shailendra Kumar Dhar Dwivedi holds 1 patent for his invention titled "Aryl naphthyl methanone oxime(s) and process for preparation thereof." This patent relates to substituted aryl naphthyl methanone oximes of general formula (I). The invention includes their process for preparation, derivatives, salts, and pharmaceutical compositions. It is particularly aimed at treating chronic myelogenous leukemia, acute myelogenous leukemia, lymphoma, multiple myeloma, and solid tumor-forming cell lines, including breast cancer, endometrial cancer, colon cancer, and prostate cancer. Additionally, it addresses the killing of drug-resistant cancer stem cells.

Career Highlights

Shailendra Kumar Dhar Dwivedi is associated with the Council of Scientific & Industrial Research, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on addressing critical health challenges.

Collaborations

Some of his notable coworkers include Sabyasachi Sanyal and Atul Kumar. Their collaborative efforts contribute to the advancement of research in the field of cancer treatment.

Conclusion

Shailendra Kumar Dhar Dwivedi's contributions to cancer treatment through his innovative patents highlight the importance of research in pharmaceuticals. His work not only showcases his expertise but also reflects a dedication to improving patient outcomes in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…